67 related articles for article (PubMed ID: 8496635)
1. [Blood flow pattern and tumor vascular change following intraperitoneal administration of CDDP in VX2 ovarian tumor].
Hasegawa E
Nihon Sanka Fujinka Gakkai Zasshi; 1993 May; 45(5):451-6. PubMed ID: 8496635
[TBL] [Abstract][Full Text] [Related]
2. [Assessment of tissue platinum concentration, X-ray computed tomogram, and microangiography after CDDP intraperitoneal administration in VX2 ovarian tumor].
Hasegawa E; Watanabe H; Machida K; Ohmura G; Hirakawa S; Momose K
Gan To Kagaku Ryoho; 1991 Aug; 18(11):2038-41. PubMed ID: 1877847
[TBL] [Abstract][Full Text] [Related]
3. [The hypertensive effect induced with angiotensin II and the physiological and pharmacokinetic aspects of two-route chemotherapy using CDDP and STS].
Takizawa K; Harada M; Fujimaru J; Shima Y; Yokoo I; Ozaki I; Sato M; Iguchi T; Takeda Y
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1569-74. PubMed ID: 2389950
[TBL] [Abstract][Full Text] [Related]
4. [The clinical and pharmacokinetic evaluation of two-route chemotherapy with cisplatin and sodium thiosulfate in combination with angiotensin II].
Takizawa K; Harada M; Fujimaru J; Matsushiro N; Shima Y; Andoh I; Satoh M; Yokoo I; Iguchi T; Hirabayashi K
Nihon Sanka Fujinka Gakkai Zasshi; 1992 May; 44(5):595-602. PubMed ID: 1619320
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacokinetics of CDDP by the route of administration in patients with ovarian cancer].
Takada M; Usui N; Suzuki M; Furugen Y; Yamamoto T
Nihon Sanka Fujinka Gakkai Zasshi; 1993 Feb; 45(2):99-105. PubMed ID: 8429253
[TBL] [Abstract][Full Text] [Related]
6. [Intraperitoneal high-dose cisplatinum chemotherapy (CDDP-ip) in patients with carcinomatous peritonitis].
Noda T; Oku M; Kiyozuka Y; Ninomiya Y; Hino K; Okamura Y; Maruyama M; Ichijo M
Gan To Kagaku Ryoho; 1987 Apr; 14(4):1025-32. PubMed ID: 3566301
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of two-route chemotherapy using cis-diamminedichloroplatinum(II) and its antidote, sodium thiosulfate, in combination with angiotensin II in a rat limb tumor.
Kuroiwa T; Aoki K; Taniguchi S; Hasuda K; Baba T
Cancer Res; 1987 Jul; 47(14):3618-23. PubMed ID: 3594429
[TBL] [Abstract][Full Text] [Related]
8. Improvement in intraperitoneal intraoperative cisplatin exposure based on pharmacokinetic analysis in patients with ovarian cancer.
Royer B; Delroeux D; Guardiola E; Combe M; Hoizey G; Montange D; Kantelip JP; Chauffert B; Heyd B; Pivot X
Cancer Chemother Pharmacol; 2008 Mar; 61(3):415-21. PubMed ID: 17503047
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacokinetics following intraperitoneal infusion of cisplatinum with and without sodium thiosulfate rescue in carcinomatous peritonitis in advanced gastric cancers].
Namatame K; Kou Y; Nakayoshi A
Gan To Kagaku Ryoho; 1991 Aug; 18(11):1784-9. PubMed ID: 1877818
[TBL] [Abstract][Full Text] [Related]
10. [Intraperitoneal chemotherapy of CDDP and etoposide in patients with advanced ovarian cancer].
Hirashima Y; Shimura T; Tanaka Y; Demukai H; Kubota T; Kobayashi T; Suzuki A
Gan To Kagaku Ryoho; 1993 Aug; 20(10):1321-6. PubMed ID: 8346930
[TBL] [Abstract][Full Text] [Related]
11. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
[TBL] [Abstract][Full Text] [Related]
12. Experimental study on paratumoral injection of cisplatin-loaded microspheres for gastric cancer.
Narita K; Ikuta H; Hamabe Y; Kuroda Y
Kobe J Med Sci; 1999 Oct; 45(5):229-43. PubMed ID: 10853189
[TBL] [Abstract][Full Text] [Related]
13. [Selective enhancement of tumor blood flow and drug delivery to brain tumors in experimental rat gliomas under angiotensin II-induced hypertension].
Ogasawara H; Kiya K; Kurisu K; Hotta T; Mikami T; Sugiyama K; Uozumi T
No To Shinkei; 1991 Jul; 43(7):657-62. PubMed ID: 1910950
[TBL] [Abstract][Full Text] [Related]
14. [Chemotherapy in malignant gynecologic tumors using intraperitoneal catheter with a subcutaneous reservoir].
Shimizu A; Kimura T; Funatsu M; Hada Y; Araki H; Notake Y
Gan To Kagaku Ryoho; 1991 Aug; 18(11):1795-9. PubMed ID: 1877820
[TBL] [Abstract][Full Text] [Related]
15. [Augmentative effects of radiofrequency hyperthermia (RFH) combined with intraperitoneal (IP) administration of CDDP in ovarian cancer].
Ino Y; Takizawa K; Isono T; Sato M; Yokoo I; Iguchi T; Takeda Y; Yokoyama M
Gan To Kagaku Ryoho; 1988 Jun; 15(6):1887-91. PubMed ID: 3382241
[TBL] [Abstract][Full Text] [Related]
16. Intravenous chemotherapy with cisplatin for regional lymph node metastases of auricular VX2 carcinoma.
Dünne AA; Kuropkat C; Sapundzhiev N; Ramaswamy A; Sesterhenn A; Schulz S; Werner JA
Anticancer Res; 2004; 24(3a):1785-9. PubMed ID: 15274356
[TBL] [Abstract][Full Text] [Related]
17. Complete inhibition of human ovarian cancer xenografts in nude mice by suramin and cis-diamminedichloroplatinum(II).
Kikuchi Y; Hirata J; Hisano A; Tode T; Kita T; Nagata I
Gynecol Oncol; 1995 Jul; 58(1):11-5. PubMed ID: 7789875
[TBL] [Abstract][Full Text] [Related]
18. [An experimental study of chemoembolization for VX2 bone tumors].
Komatsu T
Nihon Seikeigeka Gakkai Zasshi; 1995 Jan; 69(1):30-42. PubMed ID: 7699296
[TBL] [Abstract][Full Text] [Related]
19. In vivo studies of adenovirus-mediated p53 gene therapy for cis-platinum-resistant human ovarian tumor xenografts.
Song K; Cowan KH; Sinha BK
Oncol Res; 1999; 11(3):153-9. PubMed ID: 10527075
[TBL] [Abstract][Full Text] [Related]
20. [Enhancement of vascular level in tumors under angiotensin-induced hypertension].
Hori K; Suzuki M; Abe I; Saito S
Gan To Kagaku Ryoho; 1985 Jun; 12(6):1323-30. PubMed ID: 4004292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
